Medicate Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.40 M
as on 16-11-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.06 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.46 Cr
as on 16-11-2024
- Revenue 8.81%
(FY 2023)
- Profit -3.22%
(FY 2023)
- Ebitda -19.13%
(FY 2023)
- Net Worth 259.94%
(FY 2023)
- Total Assets 58.80%
(FY 2023)
About Medicate Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 3.40 M.
The company currently has active open charges totaling ₹5.06 Cr. The company has closed loans amounting to ₹1.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anita Singh, Pawan Thakur, Jogesh Agarwal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999WB2017PTC218874
- Company No.
218874
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2017
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medicate Healthcare?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jogesh Agarwal  | Director | 06-Jan-2017 | Current |
| Anita Singh | Director | 06-Jan-2017 | Current |
| Pawan Thakur | Additional Director | 02-Jul-2024 | Current |
| Subhankar Datta | Director | 06-Jan-2017 | Current |
| Soni Tiwari | Additional Director | 02-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Medicate Healthcare.
Medicate Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.81% increase. The company also saw a slight decrease in profitability, with a 3.22% decrease in profit. The company's net worth Soared by an impressive increase of 259.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicate Healthcare?
In 2023, Medicate Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jul 2024 | ₹1.40 Cr | Open |
Others Creation Date: 28 Mar 2024 | ₹1.47 M | Open |
Others Creation Date: 17 Oct 2023 | ₹1.37 Cr | Open |
How Many Employees Work at Medicate Healthcare?
Unlock and access historical data on people associated with Medicate Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicate Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicate Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
